Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 4756-4761, September 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Erratum (v49,p2522)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hutchins, D. A.
Right arrow Articles by Tannenbaum, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hutchins, D. A.
Right arrow Articles by Tannenbaum, S. R.

Isolation and Characterization of the Major Fluoranthene-Hemoglobin Adducts Formed in Vivo in the Rat1

Deborah A. Hutchins, Paul L. Skipper, Stephen Naylor and Steven R. Tannenbaum2

Department of Applied Biological Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139

The binding of fluoranthene (FA) to hemoglobin was studied both in vitro and in vivo in the rat. The in vitro binding of microsomally activated FA to rat hemoglobin appeared to involve the fluoranthene 2,3-dihydrodiol-1,10b-epoxides. Three classes of hemoglobin adducts were observed in rats chronically administered FA in the diet. Based on high pressure liquid chromatography retention times, UV and mass spectral evidence, and behavior upon cis-diol affinity chromatography, the major class of globin adducts formed in vivo was demonstrated to result from binding of syn and anti isomers of FA 2,3-dihydrodiol-1,10b-epoxides to ß-cysteine-125 of rat hemoglobin. These adducts represented at least 41% of the total binding to globin. A minor class of adducts (12% of the total binding) appeared to involve the binding of an unidentified FA metabolite to the same cysteine residue to the protein. A substantial portion of FA binding to rat hemoglobin in vivo (29%) involved metabolic pathways which were not duplicated by simple in vitro systems. That portion of the binding to globin has not been characterized.

1 This investigation was supported by USPHS Grant ES01640, awarded by the NIH, and by NIH Grant RR00317 from the Biotechnology Resources Branch, Division of Research Resources (Principal Investigator, Professor K. Biemann), which supported the mass spectrometry.

2 To whom requests for reprints should be addressed.

Received 2/18/88. Revised 5/ 4/88. Accepted 5/16/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.